Pharma Legal Handbook Join industry executives in staying informed on the market access and HTA process in Switzerland. 1. Please describe the main cost containment policies in place in your country and their fundamental principles: a. Pricing and impact of generic/biosimilar approval Based on a price comparison with 15 reference countries (containing among…
Pharma Legal Handbook Join industry executives in staying informed on the market access and HTA process in Denmark. 1. Please describe the main cost containment policies in place in your country and their fundamental principles On an overall level, control of healthcare expenditures is based on budget laws and annual agreements between…
Pharma Legal Handbook Join industry executives in staying informed on the market access and HTA process in Brazil. 1. Please describe the main cost containment policies in place in your country and their fundamental principles a. Pricing and impact of generic/biosimilar approval Generic drugs must have their PF 35% cheaper than the corresponding…
Pharma Legal Handbook 1. Please describe the main cost containment policies in place in your country and their fundamental principles: a. Pricing and impact of generic/biosimilar approval The entry of generics/biosimilars into the market affects the price of original drugs by three main mechanisms: (i) homogeneous groups (“HG”), (ii) reference groups (“RG”), (iii)…
See our Cookie Privacy Policy Here